CLINICAL_TRIALS
trial_result
· 2012-10-05
Clinical Trial Update: Safety Study of Ivacaftor in Subjects With Cystic Fibrosis [Phase 2]
Summary
Phase 2 safety study of Ivacaftor in subjects with cystic fibrosis completed. Results posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Cystic Fibrosis | Phase 2 | Status: COMPLETED | Results posted: 2012-10-05